CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data
Do Young Kim, Hye Jin Kim, Kwang-Hyub Han, Sang Young Han, Jeong Heo, Hyun Young Woo, Soon Ho Um, Yeul Hong Kim, Young Oh Kweon, Ho Yeong Lim, Jung Hwan Yoon, Wan Sik Lee, Byung Seok Lee, Han Chu Lee, Baek-Yeol Ryoo, Seung Kew Yoon
Cancer Research and Treatment. 2016;48(4):1243-1252.   Published online 2016 February 24    DOI: https://doi.org/10.4143/crt.2015.278

Excel Download

Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data
Cancer Research and Treatment. 2016;48(4):1243-1252   Crossref logo
Link1 Link2 Link3

Sorafenib for Advanced Hepatocellular Carcinoma: A Real-Life Experience
Digestive Diseases. 2018;36(5):377-384   Crossref logo
Link1 Link2

Global GIDEON data: Subgroup analysis of sorafenib dosing pattern in patients with unresectable hepatocellular carcinoma
Annals of Oncology. 2016;27:vii90   Crossref logo
Link1 Link2 Link3

A real-life experience of sorafenib treatment for patients with advanced hepatocellular carcinoma: a retrospective analysis at Cathay General Hospital, 2007–2015

Drug Design, Development and Therapy. 2019;Volume 13:397-404   Crossref logo
Link1 Link2

Sorafenib for the treatment of hepatocellular carcinoma: a single-centre real-world study
Radiology and Oncology. 2020;54(2):233-236   Crossref logo
Link1 Link2

Treatment with sorafenib on hepatocellular carcinoma −10 years’ experience in a nursing-led outpatient clinic
Journal of Hepatology. 2020;73:S562   Crossref logo
Link1 Link2

Severe toxicity caused by sorafenib in hepatocellular carcinoma match the data from renal cell carcinoma
British Journal of Cancer. 2012;106(6):1246-1246   Crossref logo
Link1 Link2 Link3

Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study
International Journal of Clinical Practice. 2010;64(8):1034-1041   Crossref logo
Link1

Hepatocellular Carcinoma: Portuguese Data in Chronic Hepatitis B Patients on Antiviral Therapy and Treatment Results With Sorafenib
GE Portuguese Journal of Gastroenterology. 2016;23(5):231-232   Crossref logo
Link1 Link2

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma: Preliminary Toxicity and Activity Data in Dogs
Cancers. 2020;12(5):1272   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.